We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$71.3B
1-Year Est. Return
56.8%
This Fund
S&P 500
This Quarter
Est. Return
+24.89%
1 Year Est. Return
+56.8%
3 Year Est. Return
+170.28%
5 Year Est. Return
+249.16%
10 Year Est. Return
+1,007.9%
AUM
$71.3B
AUM Growth
+$6.48B
(+10%)
Cap. Flow
-$2.43B
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
29.48%
Holding
1,130
New
174
Increased
291
Reduced
392
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$353M |
| 2 |
Marvell Technology
MRVL
|
+$150M |
| 3 |
Spyre Therapeutics
SYRE
|
+$126M |
| 4 |
BridgeBio Pharma
BBIO
|
+$116M |
| 5 |
Dover
DOV
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$713M |
| 2 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$355M |
| 3 |
CTRA
Coterra Energy
CTRA
|
+$289M |
| 4 |
Royalty Pharma
RPRX
|
+$259M |
| 5 |
Eli Lilly
LLY
|
+$236M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.29% |
| 2 | Healthcare | 14.03% |
| 3 | Financials | 12.39% |
| 4 | Industrials | 8.94% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Spotify
SPOT
$108B
| $82.2M | 0.12% |
179,000
+159,000
| +795% | +$75.8M |
|
177
CBRE Group
CBRE
$40.4B
| $81.9M | 0.11% |
607,781
+207,481
| +52% | +$28.6M |
|
178
LPL Financial
LPLA
$27.5B
| $81.4M | 0.11% |
289,000
+225,000
| +352% | +$67.5M |
|
179
Ferguson
FERG
$43.2B
| $80.7M | 0.11% |
340,114
-366,226
| -52% | -$88.4M |
|
180
Freeport-McMoran
FCX
$109B
| $80.6M | 0.11% |
1,281,200
+243,700
| +23% | +$15.7M |
|
181
Teva Pharmaceuticals
TEVA
$42.9B
| $80M | 0.11% |
+2,360,728
| New | +$78.6M |
|
182
Gulfport Energy Corp
GPOR
$3.12B
| $79.8M | 0.11% |
470,059
+10,000
| +2% | +$1.81M |
|
183
American Tower
AMT
$81.7B
| $79.4M | 0.11% |
485,205
+65,800
| +16% | +$11.8M |
|
184
Allegro MicroSystems
ALGM
$6.68B
| $78.1M | 0.11% |
1,121,950
-342,787
| -23% | -$16M |
|
185
Fortinet
FTNT
$115B
| $77.6M | 0.11% |
504,990
+28,700
| +6% | +$3.32M |
|
186
Synopsys
SNPS
$75.4B
| $76.2M | 0.11% |
170,761
+7,077
| +4% | +$3.33M |
|
187
Ameren
AEE
$29.4B
| $75.6M | 0.11% |
668,690
+291,100
| +77% | +$32.2M |
|
188
DoorDash
DASH
$85.5B
| $75.5M | 0.11% |
409,300
-355,600
| -46% | -$58.8M |
|
|
XIFR
189
XPLR Infrastructure LP
XIFR
$1.11B
| $75.3M | 0.11% |
6,380,000
+1,880,000
| +42% | +$21M |
|
190
Silicon Laboratories
SLAB
$7.33B
| $75M | 0.11% |
343,163
-223,174
| -39% | -$48.3M |
|
191
RPM International
RPM
$12.7B
| $72.6M | 0.1% |
653,000
+333,000
| +104% | +$34.7M |
|
192
Automatic Data Processing
ADP
$105B
| $71.9M | 0.1% |
321,276
-29,400
| -8% | -$6.28M |
|
193
Alkermes
ALKS
$7.62B
| $71.7M | 0.1% |
+1,368,000
| New | +$53.4M |
|
194
Boston Scientific
BSX
$65.2B
| $71.3M | 0.1% |
1,670,022
-2,963,215
| -64% | -$161M |
|
195
Robinhood
HOOD
$104B
| $70.7M | 0.1% |
705,100
-2,900
| -0.4% | -$243K |
|
|
KLRA
196
Kailera Therapeutics
KLRA
$1.92B
| $70.7M | 0.1% |
+3,208,286
| New | +$70.5M |
|
|
SION
197
Sionna Therapeutics
SION
$338M
| $70.4M | 0.1% |
1,600,000
+1,450,000
| +967% | +$58M |
|
198
Sherwin-Williams
SHW
$77.8B
| $70.4M | 0.1% |
204,406
-124,100
| -38% | -$39.6M |
|
199
EyePoint Inc
EYPT
$374M
| $69M | 0.1% |
4,827,792
+1,527,792
| +46% | +$20.4M |
|
200
Comcast
CMCSA
$87.3B
| $68.1M | 0.1% |
2,775,359
-139,300
| -5% | -$3.59M |
|
Similar funds
Adage Capital Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Adage Capital Partners held 1,130 positions worth $71.3B, up 10% from $64.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Adage Capital Partners withdrew a net $2.43B in Q2 2026, closing 128 positions and reducing 392 holdings. Its most notable exit was Centessa Pharmaceuticals, an estimated $355M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Marvell Technology worth $222M.
- Adage Capital Partners's largest Q2 2026 buy was Marvell Technology: 745,800 shares worth $222M.
- Adage Capital Partners added most to Devon Energy in Q2 2026, an estimated $353M increase.
- Adage Capital Partners's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $713M.
- Adage Capital Partners fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $355M.
- Adage Capital Partners's ten largest holdings make up 29% of its $71.3B portfolio in Q2 2026.
- Adage Capital Partners opened 174 new positions and closed 128 in Q2 2026.
- Adage Capital Partners's portfolio value rose 10% quarter-over-quarter to $71.3B.
Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.